Investors are not wasting any time putting their money on marijuana stocks, as the industry generated $8.5 billion in spending in the U.S. last year and is expected to reach $23.4 billion by 2022. However, the current “hot” marijuana stock market is as attractive as it is risky for investors simply because it is still at a very early stage. Let’s take a look at the top ... Continue Reading
marijuana business
The Vast Business Opportunities of Legal Cannabis
Could the cannabis industry trend be heralding a new gold rush? This post from City A.M. discusses how legal cannabis is raising the bar for investment possibilities and creativity. Is cannabis the new gold? And if so, are we at the gates of a greener and much more lucrative gold rush? Long gone are the days in which the legalisation of marijuana seemed impossible. Across ... Continue Reading
Legal Cannabis Shortage: Who Will Pay the Price?
Numerous legal cannabis stores in Canada are dealing with empty shelves and disgruntled customers, with fears consumers will turn to black market. This post from The Guardian discusses the weed woes of Canada and their struggle to meet the huge demand for legal cannabis. When Trevor Tobin opened one of Canada’s first legal cannabis stores last month, he had high hopes of ... Continue Reading
Why the Time Is Right for A Marijuana Edibles Business
The cannabis curious, who are reluctant to smoke, find the idea of marijuana, masked as a delicious edible, interesting. In this post from Entrepreneur.com, learn why marijuana edibles make for a huge business opportunity. There are many ways to earn money in the marijuana industry without growing or selling marijuana flower. Increasingly, the most popular is through the ... Continue Reading
Future of Medical Cannabis Under New FDA Chief
Scott Gottlieb has been picked by Trump to head the US Food & Drug Administration. This post from Doctor Frank highlights what this means for medical cannabis. So, it looks like Scott Gottlieb, MD, will be appointed Director of the Food & Drug Administration (FDA), much to the cheer of those in the pharmaceutical and biotech industries. Gottlieb seems to favor faster ... Continue Reading